SLAMF7 and monoclonal gammopathy: Immunophenotyping has greatly contributed also in the research of monoclonal gammopathies and may be of significant importance in the upcoming era of immunotherapy, especially in defining and monitoring therapeutic targets such as CD38, SLAMF7, PD-L1, BCMA and many others that are yet to be discovered.107, 108